NATURAL-HISTORY OF THYROID-ASSOCIATED OPHTHALMOPATHY

被引:155
作者
PERROS, P
CROMBIE, AL
KENDALLTAYLOR, P
机构
[1] UNIV NEWCASTLE UPON TYNE,SCH MED,DEPT MED,NEWCASTLE TYNE NE2 4HH,TYNE & WEAR,ENGLAND
[2] UNIV NEWCASTLE UPON TYNE,SCH MED,DEPT OPHTHALMOL,NEWCASTLE TYNE NE2 4HH,TYNE & WEAR,ENGLAND
关键词
D O I
10.1111/j.1365-2265.1995.tb02597.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND The natural history of thyroid associated ophthalmopathy is poorly documented, although it is widely thought that many cases improve spontaneously with time. This has important implications in the management of patients and is also a critical factor when assessing the effects of different treatments. OBJECTIVE To document the natural history of thyroid associated ophthalmopathy, 59 patients were studied longitudinally and the severity of eye disease documented at regular intervals. METHODS Fifty-nine patients with thyroid associated ophthalmopathy who had not received immunosuppressive or surgical treatment for their eye disease, were recruited from a combined thyroid-eye clinic. They were assessed at presentation and at 3-6-monthly intervals for a median of 12 months. The eyes were assessed by separate and objective measurements relating to the status of the eyelids, cornea, extraocular muscles, proptosis and optic nerve function. In addition, a scoring system based on the above measurements was used to grade the overall severity of eye disease. RESULTS Thirteen patients (22%) improved substantially, 25 patients (42.4%) showed minor improvement, 13 patients (22%) did not change, and 8 patients (13.5%) deteriorated progressively, to the extent that immunosuppressive treatment was considered to be necessary. CONCLUSIONS A significant proportion of patients with thyroid associated ophthalmopathy (64.4% in the present series) improve spontaneously so serial assessment plays an important part in deciding which patients require immunosuppressive treatment. These findings also support the view that clinical trials designed to test the efficacy of new treatments in thyroid associated ophthalmopathy should be scrupulously controlled to allow for the natural tendency towards remission.
引用
收藏
页码:45 / 50
页数:6
相关论文
共 18 条
[1]  
ARANOW H, 1965, J CLIN ENDOCR METAB, V25, P1
[2]   EMERGENCY TREATMENT OF GRAVES OPHTHALMOPATHY [J].
BAHN, RS ;
BARTLEY, GB ;
GORMAN, CA .
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1992, 6 (01) :95-105
[3]  
ENZMANN DR, 1979, J COMPUT ASSIST TOMO, V3, P815
[4]   THYROID-ASSOCIATED EYE DISEASE - CLINICAL MANAGEMENT [J].
FELLS, P .
LANCET, 1991, 338 (8758) :29-32
[5]  
GORMAN CA, 1983, MAYO CLIN PROC, V58, P515
[6]  
HALES IB, 1960, Q J MED, V29, P113
[7]   THE ENDOCRINE EYE LESION IN HYPERTHYROIDISM - ITS INCIDENCE AND COURSE IN 165 PATIENTS TREATED FOR THYROTOXICOSIS WITH IODINE-131 [J].
HAMILTON, HE ;
SCHULTZ, RO ;
DEGOWIN, EL .
ARCHIVES OF INTERNAL MEDICINE, 1960, 105 (05) :675-685
[8]   ENDOCRINE OPHTHALMOPATHY - CURRENT IDEAS CONCERNING ETIOLOGY, PATHOGENESIS, AND TREATMENT [J].
JACOBSON, DH ;
GORMAN, CA .
ENDOCRINE REVIEWS, 1984, 5 (02) :200-220
[9]   STUDIES ON PATHOGENESIS OF OPHTHALMOPATHY OF GRAVES DISEASE [J].
KRISS, JP ;
PLESHAKOV, V ;
ROSENBLUM, AL ;
HOLDERNESS, M ;
SHARP, G ;
UTIGER, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1967, 27 (04) :582-+
[10]   STUDIES ON THE OCCURRENCE OF OPHTHALMOPATHY IN GRAVES-DISEASE [J].
MARCOCCI, C ;
BARTALENA, L ;
BOGAZZI, F ;
PANICUCCI, M ;
PINCHERA, A .
ACTA ENDOCRINOLOGICA, 1989, 120 (04) :473-478